819 related articles for article (PubMed ID: 12173133)
1. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.
Sundar S; Sahu M; Mehta H; Gupta A; Kohli U; Rai M; Berman JD; Murray HW
Clin Infect Dis; 2002 Sep; 35(5):581-6. PubMed ID: 12173133
[TBL] [Abstract][Full Text] [Related]
2. K39 strip test--easy, reliable and cost-effective field diagnosis for visceral leishmaniasis in India.
Goswami RP; Bairagi B; Kundu PK
J Assoc Physicians India; 2003 Aug; 51():759-61. PubMed ID: 14651134
[TBL] [Abstract][Full Text] [Related]
3. Rapid accurate field diagnosis of Indian visceral leishmaniasis.
Sundar S; Reed SG; Singh VP; Kumar PC; Murray HW
Lancet; 1998 Feb; 351(9102):563-5. PubMed ID: 9492776
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
Mathur P; Samantaray J; Chauhan NK
Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
[TBL] [Abstract][Full Text] [Related]
5. Rapid, noninvasive diagnosis of visceral leishmaniasis in India: comparison of two immunochromatographic strip tests for detection of anti-K39 antibody.
Sundar S; Maurya R; Singh RK; Bharti K; Chakravarty J; Parekh A; Rai M; Kumar K; Murray HW
J Clin Microbiol; 2006 Jan; 44(1):251-3. PubMed ID: 16390983
[TBL] [Abstract][Full Text] [Related]
6. PCR for diagnosis and assessment of cure in kala-azar patients in Bangladesh.
Salam MA; Mondal D; Kabir M; Ekram AR; Haque R
Acta Trop; 2010 Jan; 113(1):52-5. PubMed ID: 19769932
[TBL] [Abstract][Full Text] [Related]
7. New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine.
Sundar S; Rai M; Chakravarty J; Agarwal D; Agrawal N; Vaillant M; Olliaro P; Murray HW
Clin Infect Dis; 2008 Oct; 47(8):1000-6. PubMed ID: 18781879
[TBL] [Abstract][Full Text] [Related]
8. Sero-epidemiological study of kala-azar in a village of Varanasi district, India.
Kumar R; Pai K; Kumar P; Pandey HP; Sundar S
Trop Med Int Health; 2006 Jan; 11(1):41-8. PubMed ID: 16398754
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis.
Singh S; Gilman-Sachs A; Chang KP; Reed SG
J Parasitol; 1995 Dec; 81(6):1000-3. PubMed ID: 8544037
[TBL] [Abstract][Full Text] [Related]
10. Utility of K39 strip test in visceral leishmaniasis (VL) and HIV co-infected patients: an early report from Eastern India.
Goswami RP; Rahman M; Guha SK
J Assoc Physicians India; 2007 Feb; 55():154-5. PubMed ID: 17571750
[No Abstract] [Full Text] [Related]
11. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of visceral leishmaniasis in India.
Bora D
Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
[TBL] [Abstract][Full Text] [Related]
13. False-positive results of a rapid K39-based strip test and Chagas disease.
Amato Neto V; Amato VS; Tuon FF; Gakiya E; de Marchi CR; de Souza RM; Furucho CR
Int J Infect Dis; 2009 Mar; 13(2):182-5. PubMed ID: 18786847
[TBL] [Abstract][Full Text] [Related]
14. Application of electroimmunodiffusion and crossed electroimmunodiffusion tests for the diagnosis of visceral leishmaniasis (kala-azar).
Kohanteb J; Rezai HR; Ardehali S
J Trop Med Hyg; 1984 Oct; 87(5):201-5. PubMed ID: 6442365
[TBL] [Abstract][Full Text] [Related]
15. Post kala azar dermal leishmaniasis in Sudan.
Kordofani YM; Nour YT; El-Hassan AM; Shalayel MH
East Mediterr Health J; 2001 Nov; 7(6):1061-4. PubMed ID: 15332749
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village.
Bern C; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Amann J; Wahed MA; Wagatsuma Y; Breiman RF; Williamson J; Secor WE; Maguire JH
Am J Trop Med Hyg; 2007 May; 76(5):909-14. PubMed ID: 17488915
[TBL] [Abstract][Full Text] [Related]
17. Presence of anti-Lepp12 antibody: a marker for diagnostic and prognostic evaluation of visceral leishmaniasis.
Kumar D; Srividya G; Verma S; Singh R; Negi NS; Fragaki K; Kubar J; Salotra P
Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):167-71. PubMed ID: 18177681
[TBL] [Abstract][Full Text] [Related]
18. Kala-azar (visceral Leishmaniasis) from Khotang.
Joshi S; Bajracharya BL; Baral MR
Kathmandu Univ Med J (KUMJ); 2006; 4(2):232-4. PubMed ID: 18603904
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the diagnosis and treatment of kala-azar.
Sundar S; Chakravarty J
Natl Med J India; 2012; 25(2):85-9. PubMed ID: 22686715
[TBL] [Abstract][Full Text] [Related]
20. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen.
Singh S; Kumari V; Singh N
Clin Diagn Lab Immunol; 2002 May; 9(3):568-72. PubMed ID: 11986261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
